Literature DB >> 11948405

Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function.

Laurent Bartholin1, Véronique Maguer-Satta, Sandrine Hayette, Sylvie Martel, Mylène Gadoux, Laura Corbo, Jean-Pierre Magaud, Ruth Rimokh.   

Abstract

Signaling of TGFbeta family members such as activin is tightly regulated by soluble binding proteins. Follistatin binds to activin A with high affinity, and prevents activin binding to its own receptors, thereby blocking its signaling. We previously identified FLRG gene from a B-cell leukemia carrying a t(11;19)(q13;p13) translocation. We and others have already shown that FLRG, which is highly homologous to follistatin, may be involved in the regulation of the activin function through its binding to activin. In this study, we found that, like follistatin, FLRG protein inhibited activin A signaling as demonstrated by the use of a transcriptional reporter assay, and blocked the activin A-induced growth inhibition of HepG2 cells. We have recently shown that the TGFbeta-induced expression of FLRG occurs at a transcriptional level through the action of Smad proteins. Here we show that activin A increases FLRG and follistatin at both the mRNA and protein levels. We found that Smad proteins are involved in the activin A-induced transcription activation of FLRG and follistatin. Finally we demonstrate that FLRG protein regulates its own activin-induced expression. In conclusion, activin A induces FLRG and follistatin expression. This observation, in conjunction with the antagonistic effect of FLRG and follistatin on activin signaling, indicates that these two proteins participate in a negative feedback loop which regulates the activin function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11948405     DOI: 10.1038/sj.onc.1205294

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  Induction of follistatin precedes gastric transformation in gastrin deficient mice.

Authors:  Weiqun Kang; Milena Saqui-Salces; Yana Zavros; Juanita L Merchant
Journal:  Biochem Biophys Res Commun       Date:  2008-09-17       Impact factor: 3.575

2.  Impaired FSHbeta expression in the pituitaries of Foxl2 mutant animals.

Authors:  Nicholas J Justice; Amy L Blount; Emanuele Pelosi; David Schlessinger; Wylie Vale; Louise M Bilezikjian
Journal:  Mol Endocrinol       Date:  2011-06-23

3.  The Local Control of the Pituitary by Activin Signaling and Modulation.

Authors:  Louise M Bilezikjian; Wylie W Vale
Journal:  Open Neuroendocrinol J       Date:  2011-01-01

Review 4.  Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle.

Authors:  Lea M Beaulieu; Brandi R Whitley; Theodore F Wiesner; Sophie M Rehault; Diane Palmieri; Abdel G Elkahloun; Frank C Church
Journal:  Bioessays       Date:  2007-10       Impact factor: 4.345

Review 5.  Follistatin as potential therapeutic target in prostate cancer.

Authors:  Maria Vittoria Sepporta; Francesca Maria Tumminello; Carla Flandina; Marilena Crescimanno; Marco Giammanco; Maurizio La Guardia; Danila di Majo; Gaetano Leto
Journal:  Target Oncol       Date:  2013-03-01       Impact factor: 4.493

6.  Hypoxia enhances the expression of follistatin-like 3 in term human trophoblasts.

Authors:  T Biron-Shental; W T Schaiff; E Rimon; T L Shim; D M Nelson; Y Sadovsky
Journal:  Placenta       Date:  2007-10-23       Impact factor: 3.481

Review 7.  Activins and activin antagonists in hepatocellular carcinoma.

Authors:  Alev Deli; Emanuel Kreidl; Stefan Santifaller; Barbara Trotter; Katja Seir; Walter Berger; Rolf Schulte-Hermann; Chantal Rodgarkia-Dara; Michael Grusch
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

8.  Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto.

Authors:  Paul W Harms; Chenbei Chang
Journal:  Genes Dev       Date:  2003-10-16       Impact factor: 11.361

9.  Peroxisome proliferator-activated receptor gamma down-regulates follistatin in intestinal epithelial cells through SP1.

Authors:  Brian M Necela; Weidong Su; E Aubrey Thompson
Journal:  J Biol Chem       Date:  2008-09-03       Impact factor: 5.157

10.  Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes.

Authors:  Kalyani D Panse; Leanne E Felkin; Marina M López-Olañeta; Jesús Gómez-Salinero; María Villalba; Lucía Muñoz; Kazuto Nakamura; Masayuki Shimano; Kenneth Walsh; Paul J R Barton; Nadia Rosenthal; Enrique Lara-Pezzi
Journal:  J Cardiovasc Transl Res       Date:  2012-08-23       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.